---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-088108"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:06:40.005155+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MindMed prices $75M public offering of common shares and pre-funded warrants; cash position $243.1M

## Summary
- Underwritten public offering of 9,285,511 common shares at $7.00/share and 1,428,775 pre-funded warrants at $6.999/warrant.
- Gross proceeds of ~$75M; net proceeds of ~$70M after underwriting discounts and expenses.
- Preliminary cash and cash equivalents of ~$243.1M as of June 30, 2024, disclosed in prospectus supplement.
- Offering expected to close on August 12, 2024; net proceeds to fund R&D and working capital.
- Leerink Partners and Evercore ISI acting as joint bookrunning managers; RBC and Oppenheimer as lead managers.

## SEC filing metadata
- accession: 0001104659-24-088108
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000110465924088108/0001104659-24-088108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000110465924088108/tm2420790d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-088108
- JSON: https://secwatch.observer/filing/0001104659-24-088108.json
- Plain text: https://secwatch.observer/filing/0001104659-24-088108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.